Utah Medical Products Inc (UTMD) - Total Assets

Latest as of March 2026: $124.38 Million USD

Based on the latest financial reports, Utah Medical Products Inc (UTMD) holds total assets worth $124.38 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Utah Medical Products Inc - Total Assets Trend (1987–2025)

This chart illustrates how Utah Medical Products Inc's total assets have evolved over time, based on quarterly financial data. Also see UTMD market cap overview for the company's overall valuation and market capitalisation.

Utah Medical Products Inc - Asset Composition Analysis

Current Asset Composition (December 2025)

Utah Medical Products Inc's total assets of $124.38 Million consist of 79.8% current assets and 20.2% non-current assets. Review UTMD liabilities breakdown to assess the company's total debt and financial obligations.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 70.0%
Accounts Receivable $3.52 Million 2.9%
Inventory $7.93 Million 6.5%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $840.00K 0.7%
Goodwill $14.05 Million 11.5%

Asset Composition Trend (1987–2025)

This chart illustrates how Utah Medical Products Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See UTMD share price today for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Utah Medical Products Inc's current assets represent 79.8% of total assets in 2025, an increase from 61.6% in 1987.
  • Cash Position: Cash and equivalents constituted 70.0% of total assets in 2025, up from 23.3% in 1987.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 2.0% in 1987.
  • Asset Diversification: The largest asset category is goodwill at 11.5% of total assets.

Utah Medical Products Inc Competitors by Total Assets

Key competitors of Utah Medical Products Inc based on total assets are shown below.

Company Country Total Assets
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
China CN¥12.68 Billion
Andon Health Co Ltd
SHE:002432
China CN¥29.91 Billion
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
China CN¥2.42 Billion
Pegavision
TW:6491
Taiwan NT$16.17 Billion
Nanosonics Ltd
AU:NAN
Australia AU$279.25 Million
Visco Vision Inc.
TW:6782
Taiwan NT$5.82 Billion
QITIAN Technology Group Co Ltd
SHE:300061
China CN¥1.17 Billion
Embecta Corp
NASDAQ:EMBC
USA $1.27 Billion

Utah Medical Products Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 28.64 22.29 15.93
Quick Ratio 26.15 20.29 14.55
Cash Ratio 0.00 0.00 0.00
Working Capital $96.87 Million $92.08 Million $66.16 Million

Utah Medical Products Inc - Advanced Valuation Insights

This section examines the relationship between Utah Medical Products Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.79
Latest Market Cap to Assets Ratio 1.77
Asset Growth Rate (YoY) 0.0%
Total Assets $122.54 Million
Market Capitalization $216.74 Million USD

Valuation Analysis

Above Book Valuation: The market values Utah Medical Products Inc's assets above their book value (1.77x), reflecting positive investor sentiment about the company's future prospects.

Slight Asset Contraction: Utah Medical Products Inc's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Utah Medical Products Inc (1987–2025)

The table below shows the annual total assets of Utah Medical Products Inc from 1987 to 2025.

Year Total Assets Change
2025-12-31 $122.54 Million +0.00%
2024-12-31 $122.54 Million -9.54%
2023-12-31 $135.46 Million +9.35%
2022-12-31 $123.87 Million +7.12%
2021-12-31 $115.64 Million +3.48%
2020-12-31 $111.75 Million +1.78%
2019-12-31 $109.79 Million +10.04%
2018-12-31 $99.77 Million +7.57%
2017-12-31 $92.75 Million +21.10%
2016-12-31 $76.58 Million -3.27%
2015-12-31 $79.17 Million -2.34%
2014-12-31 $81.08 Million +0.45%
2013-12-31 $80.71 Million +4.91%
2012-12-31 $76.94 Million +0.71%
2011-12-31 $76.39 Million +85.24%
2010-12-31 $41.24 Million -1.24%
2009-12-31 $41.75 Million +7.56%
2008-12-31 $38.82 Million -15.58%
2007-12-31 $45.99 Million +4.07%
2006-12-31 $44.19 Million +6.11%
2005-12-31 $41.64 Million +0.92%
2004-12-31 $41.26 Million -16.97%
2003-12-31 $49.69 Million +112.49%
2002-12-31 $23.39 Million -0.78%
2001-12-31 $23.57 Million -7.28%
2000-12-31 $25.42 Million -8.41%
1999-12-31 $27.76 Million -13.26%
1998-12-31 $32.00 Million +1.59%
1997-12-31 $31.50 Million +9.00%
1996-12-31 $28.90 Million -13.21%
1995-12-31 $33.30 Million +21.53%
1994-12-31 $27.40 Million -3.18%
1993-12-31 $28.30 Million +1.07%
1992-12-31 $28.00 Million +30.84%
1991-12-31 $21.40 Million +37.18%
1990-12-31 $15.60 Million +31.09%
1989-12-31 $11.90 Million +20.20%
1988-12-31 $9.90 Million +35.62%
1987-12-31 $7.30 Million --

About Utah Medical Products Inc

NASDAQ:UTMD USA Medical Instruments & Supplies
Market Cap
$237.62 Million
Market Cap Rank
#16333 Global
#3887 in USA
Share Price
$74.63
Change (1 day)
+5.60%
52-Week Range
$53.80 - $74.63
All Time High
$117.70
About

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including … Read more